Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Free Cash Flow: 2009-2025

Historic Free Cash Flow for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $256.6 million.

  • BIO-TECHNE's Free Cash Flow fell 59.39% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.1 million, marking a year-over-year decrease of 8.56%. This contributed to the annual value of $256.6 million for FY2025, which is 8.66% up from last year.
  • As of FY2025, BIO-TECHNE's Free Cash Flow stood at $256.6 million, which was up 8.66% from $236.1 million recorded in FY2024.
  • BIO-TECHNE's Free Cash Flow's 5-year high stood at $307.9 million during FY2021, with a 5-year trough of $216.1 million in FY2023.
  • For the 3-year period, BIO-TECHNE's Free Cash Flow averaged around $236.3 million, with its median value being $236.1 million (2024).
  • As far as peak fluctuations go, BIO-TECHNE's Free Cash Flow spiked by 100.60% in 2021, and later fell by 22.90% in 2023.
  • Yearly analysis of 5 years shows BIO-TECHNE's Free Cash Flow stood at $307.9 million in 2021, then dropped by 8.93% to $280.4 million in 2022, then dropped by 22.90% to $216.1 million in 2023, then rose by 9.23% to $236.1 million in 2024, then rose by 8.66% to $256.6 million in 2025.